Results 141 to 150 of about 67,534 (151)

Pleomorphic liposarcoma: A clinicopathologic study of 20 FNA cases

Cancer Cytopathology, 2022
Pleomorphic liposarcoma (PLPS) is the least common but most aggressive of all forms of liposarcoma (LPS). Its diagnosis relies on the recognition of pleomorphic lipoblasts (PLBs), whose numbers vary considerably. Because few large fine‐needle aspiration (
P. Wakely, S. Wangsiricharoen, Syed Z. Ali   +2 more
semanticscholar   +1 more source

Pleomorphic Liposarcoma Revisited.

Orthopedics, 2022
Pleomorphic liposarcoma (PLPS) is the rarest and more aggressive subtype of liposarcomas, accounting for 10% of all liposarcomas. The diagnosis should be considered after the detection of multivacuolated pleomorphic lipoblasts in biopsy specimens.
A. Hadjimichael, Achilles Bekos, S. Tsukamoto, Yuji Nitta, A. Righi, C. Errani, A. Mavrogenis   +6 more
semanticscholar   +1 more source

Pleomorphic Liposarcoma

American Journal of Surgical Pathology, 2022
Pleomorphic liposarcoma (PLPS) is a highly aggressive sarcoma comprising variable numbers of pleomorphic lipoblasts mixed with undifferentiated pleomorphic sarcoma (UPS)-like areas.
Sandra Gjorgova Gjeorgjievski, K. Thway, J. Dermawan, I. John, C. Fisher, B. Rubin, S.M. Jenkins, J. Thangaiah, A. Folpe, K. Fritchie   +9 more
semanticscholar   +1 more source

Pleomorphic Liposarcoma of the Extremity and Trunk: Multimodality Therapy for Some but Not All?

Journal of Surgical Oncology
Pleomorphic liposarcoma (PLPS) is an ultra‐rare malignancy distinct from well‐differentiated/dedifferentiated and myxoid liposarcoma. In this study, we sought to (1) assess outcomes after surgery for primary, non‐metastatic PLPS and (2) explore potential
William W. Tseng, F. Barretta, F. Tucci, M. Barisella, S. Radaelli, C. Colombo, D. Callegaro, C. Morosi, R. Sanfilippo, C. Fabbroni, S. Stacchiotti, Steven H Sun, P. Collini, M. Fiore, A. Gronchi   +14 more
semanticscholar   +1 more source

Pleomorphic liposarcoma of the breast.

Revista Española de Patología
Primary sarcomas of the breast are exceptionally rare, accounting for fewer than 1% of malignant breast lesions. Mammary liposarcomas comprise less than 5% of all breast sarcomas, and among these, primary pleomorphic liposarcoma is particularly uncommon,
Miriam Rubiera Valdés, Inés Gómez de la Riva, J. M. Alonso de la Campa, A. Fernández-Velasco   +3 more
semanticscholar   +1 more source

Systemic Therapy in Advanced Pleomorphic Liposarcoma: a Comprehensive Review

Current Treatment Options in Oncology, 2023
T. Assi, C. Ngo, M. Faron, B. Verret, A. Lévy, Charles Honoré, C. Hénon, C. Le Péchoux, R. Bahleda, A. Le Cesne   +9 more
semanticscholar   +1 more source

Sintilimab, doxorubicin and ifosfamide (AI) as first-line treatment in patients with advanced undifferentiated pleomorphic sarcoma (UPS), synovial sarcoma (SS), myxoid liposarcoma (MLPS) and de-differentiated liposarcoma (DDLPS): A single-arm phase 2 trial.

Journal of Clinical Oncology
11505 Background: Anti-PD-1 antibody had showed encouraging activity as salvage treatment in patients with certain subtypes of advanced soft tissue sarcoma. However, its role in first-line setting is uncertain.
Xin Liu, Yan-Jing Guo, Wang-Jun Yan, Yong Chen, Yu Xu, Chun-Meng Wang, Wei-Qiang Yao, Jian Wang, Lin Yu, Shi-Yu Jiang, Xiao-Wei Zhang, Zhi-Guo Luo   +11 more
semanticscholar   +1 more source

Pleomorphic liposarcoma: Updates and current differential diagnosis.

Seminars in diagnostic pathology, 2019
Pleomorphic liposarcoma is the least common but most aggressive subtype of liposarcoma. Tumors most commonly arise in the deep soft tissues of the extremities in adult patients.
W. J. Anderson, V. Jo
semanticscholar   +1 more source

Establishment and characterization of NCC-PLPS2-C1: a novel cell line of pleomorphic liposarcoma

Human Cell, 2022
Taro Akiyama, Yuki Yoshimatsu, Rei Noguchi, Yooksil Sin, Julia Osaki, Yuki Adachi, Takuya Ono, R. Tsuchiya, Chiaki Sato, S. Iwata, Naoki Kojima, A. Yoshida, S. Ohtori, A. Kawai, T. Kondo   +14 more
semanticscholar   +1 more source

[Myxiod pleomorphic liposarcoma: a clinicopathological and molecular genetic analysis of six cases].

Zhonghua bing li xue za zhi = Chinese journal of pathology, 2022
X.-C. Zheng, H.-J. Huang, J. You, X. Y. Lin, D.-R. Chen, Dingrong Zhong   +5 more
semanticscholar   +1 more source